Author:
Sobti R. C.,Gosipatala Sunil Babu,Reddy Pushpa,Bisht Nivedita,Kuril Shruti R.,Madhuri Kaja,Chand Gyan,Kaur Tejinder,Thakur Manish
Publisher
Springer Nature Singapore
Reference76 articles.
1. Actor JK (2019) A functional overview of the immune system and immune components. Int Immunol:1–16. https://doi.org/10.1016/B978-0-12-420030-2.00001-9
2. Albertini MR, Hank JA, Schiller JH, Khorsand M, Borchert AA, Gan J, Bechhofer R, Storer B, Reisfeld RA, Sondel PM (1997) Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients. Clin Cancer Res 3(8):1277–1288
3. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Albinger N, Hartmann J, Ullrich E (2021) Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. Gene Ther 28(9):513–527. https://doi.org/10.1038/S41434-021-00246-W
4. Andtbacka RHI, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, … Coffin RS (2015) Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol 33(25):2780–2788. https://doi.org/10.1200/JCO.2014.58.3377
5. Bareke H, Salva E, Özbaş S (2023) A new gene therapy approach by tenascin-C genome editing induces apoptosis and cell cycle arrest in triple-negative breast cancer cells. Cyprus J Med Sci 8(1):20–26. https://doi.org/10.4274/cjms.2022.2022-29